Brokerages Set Teleflex Incorporated (NYSE:TFX) Price Target at $182.63

Shares of Teleflex Incorporated (NYSE:TFX) have earned a consensus rating of “Hold” from the eleven brokerages that are currently covering the firm, MarketBeat.com reports. One equities research analyst has rated the stock with a sell rating, eight have issued a hold rating and two have issued a buy rating on the company. The average twelve-month price objective among analysts that have covered the stock in the last year is $182.63.

TFX has been the subject of several recent analyst reports. Citizens Jmp lowered shares of Teleflex from an “outperform” rating to a “market perform” rating in a report on Thursday, February 27th. Piper Sandler reaffirmed a “neutral” rating and set a $140.00 price target (down from $255.00) on shares of Teleflex in a report on Friday, February 28th. Needham & Company LLC reissued a “hold” rating on shares of Teleflex in a research note on Wednesday, March 12th. Royal Bank of Canada lowered Teleflex from an “outperform” rating to a “sector perform” rating and lowered their target price for the company from $220.00 to $155.00 in a research note on Friday, February 28th. Finally, Raymond James downgraded shares of Teleflex from an “outperform” rating to a “market perform” rating in a research report on Friday, February 28th.

Teleflex Stock Performance

Shares of NYSE:TFX opened at $131.93 on Friday. The company has a debt-to-equity ratio of 0.37, a current ratio of 2.42 and a quick ratio of 1.39. The business’s fifty day moving average price is $154.86 and its two-hundred day moving average price is $186.26. Teleflex has a fifty-two week low of $128.55 and a fifty-two week high of $249.91. The stock has a market capitalization of $6.12 billion, a price-to-earnings ratio of 26.23, a price-to-earnings-growth ratio of 1.73 and a beta of 1.19.

Teleflex (NYSE:TFX) last posted its earnings results on Thursday, February 27th. The medical technology company reported $3.89 earnings per share for the quarter, topping the consensus estimate of $3.86 by $0.03. Teleflex had a net margin of 7.85% and a return on equity of 14.19%. The business had revenue of $795.40 million for the quarter, compared to analyst estimates of $813.24 million. As a group, analysts predict that Teleflex will post 13.98 EPS for the current fiscal year.

Teleflex Announces Dividend

The firm also recently announced a quarterly dividend, which was paid on Monday, March 17th. Shareholders of record on Friday, March 7th were given a dividend of $0.34 per share. The ex-dividend date was Friday, March 7th. This represents a $1.36 dividend on an annualized basis and a yield of 1.03%. Teleflex’s payout ratio is presently 95.77%.

Institutional Trading of Teleflex

Several institutional investors and hedge funds have recently made changes to their positions in TFX. MassMutual Private Wealth & Trust FSB boosted its holdings in Teleflex by 103.1% during the first quarter. MassMutual Private Wealth & Trust FSB now owns 197 shares of the medical technology company’s stock worth $27,000 after buying an additional 100 shares during the last quarter. Headlands Technologies LLC acquired a new stake in shares of Teleflex in the 4th quarter valued at approximately $29,000. True Wealth Design LLC boosted its stake in Teleflex by 62.3% during the 4th quarter. True Wealth Design LLC now owns 271 shares of the medical technology company’s stock worth $48,000 after acquiring an additional 104 shares during the last quarter. Avior Wealth Management LLC grew its holdings in Teleflex by 81.2% during the fourth quarter. Avior Wealth Management LLC now owns 279 shares of the medical technology company’s stock valued at $50,000 after purchasing an additional 125 shares during the period. Finally, IFP Advisors Inc raised its holdings in Teleflex by 238.5% in the fourth quarter. IFP Advisors Inc now owns 308 shares of the medical technology company’s stock worth $55,000 after purchasing an additional 217 shares during the period. Institutional investors own 95.62% of the company’s stock.

Teleflex Company Profile

Teleflex Incorporated designs, develops, manufactures, and supplies single-use medical devices for common diagnostic and therapeutic procedures in critical care and surgical applications worldwide. The company provides vascular access products that comprise Arrow branded catheters, catheter navigation and tip positioning systems, and intraosseous access systems for the administration of intravenous therapies, the measurement of blood pressure, and the withdrawal of blood samples through a single puncture site.